Lazertinib, CAS 1903008-80-9

Product Description: Lazertinib (YH25448) is a potent, highly mutant-selective, blood-brain barrier permeable, orally available and irreversible third-generation EGFR tyrosine kinase inhibitor, and can be used in the research of non-small cell lung cancer[1].

Applications: Cancer-Kinase/protease

Formula: C30H34N8O3

References: [1]Byoung Chul Cho, et al. YH25448, a 3rd Generation EGFR-TKI, in Patients with EGFR-TKI-resistant NSCLC: Phase I/II Study Results.

CAS Number: 1903008-80-9

Molecular Weight: 554.64

Compound Purity: 99.07

Research Area: Cancer

Solubility: DMSO : 9 mg/mL (ultrasonic)

Target: EGFR

• SKU: MEXHY-109061-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-109061-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK